Advocate
imidacloprid / moxidectin
Table of contents
Overview
This is a summary of the European public assessment report (EPAR) for Advocate. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Advocate.
For practical information about using Advocate, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Authorisation details
Product details | |
---|---|
Name |
Advocate
|
Agency product number |
EMEA/V/C/000076
|
Active substance |
|
International non-proprietary name (INN) or common name |
imidacloprid / moxidectin
|
Species |
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QP54AB52
|
Publication details | |
---|---|
Marketing-authorisation holder |
Bayer Animal Health GmbH
|
Revision |
19
|
Date of issue of marketing authorisation valid throughout the European Union |
02/04/2003
|
Contact address |
Product information
20/02/2018 Advocate - EMEA/V/C/000076 - II/0039/G
Contents
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pharmacotherapeutic group
Therapeutic indication
Dogs
For dogs suffering from, or at risk from, mixed parasitic infections:
- For the treatment and prevention of flea infestation (Ctenocephalides felis),
- the treatment of biting lice (Trichodectes canis),
- the treatment of ear mite infestation (Otodectes cynotis), sarcoptic mange (caused by Sarcoptes scabiei var. canis), demodicosis (caused by Demodex canis),
- the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis),
- the treatment of circulating microfilariae (Dirofilaria immitis),
- the treatment of cutaneous dirofilariosis (adult stages of Dirofilaria repens)
- the prevention of cutaneous dirofilariosis (L3 larvae of Dirofilaria repens),
- the reduction of circulating microfilariae (Dirofilaria repens),
- the prevention of angiostrongylosis (L4 larvae and immature adults of Angiostrongylus vasorum),
- the treatment of Angiostrongylus vasorum and Crenosoma vulpis,
- the prevention of spirocercosis (Spirocerca lupi),
- the treatment of Eucoleus (syn. Capillaria) boehmi (adults),
- the treatment of the eye worm Thelazia callipaeda (adults),
- the treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and adults of Toxocara canis, Ancylostoma caninum and Uncinaria stenocephala, adults of Toxascaris leonina and Trichuris vulpis).
The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
Cats
For cats suffering from, or at risk from, mixed parasitic infections:
- For the treatment and prevention of flea infestation (Ctenocephalides felis),
- the treatment of ear mite infestation (Otodectes cynotis),
- the treatment of notoedric mange (Notoedres cati),
- the treatment of the lungworm Eucoleus aerophilus (syn. Capillaria aerophila) (adults),
- the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis),
- the treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and adults of Toxocara cati and Ancylostoma tubaeforme).
The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
Ferrets
For ferrets suffering from, or at risk from, mixed parasitic infections:
- For the treatment and prevention of flea infestation (Ctenocephalides felis),
- the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis).